Logo

Serologicals Shareholders Approve Millipore's $1.4B Buyout

Jul 12, 2006
NEW YORK (GenomeWeb News) - Serologicals shareholders have approved Millipore's buyout offer, Serologicals said today.
 
GenomeWeb News on April 25 reported Millipore's plan to acquire Serologicals for $1.4 billion. The shareholders will receive $31.55 per share in cash.
 
About 82 percent of shares outstanding voted in favor of the deal, the Atlanta-based company said.

Breaking News
The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.